Church & Dwight CO Inc CHD
We take great care to ensure that the data presented and summarized in this overview for CHURCH & DWIGHT CO INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHD
View all-
Vanguard Group Inc Valley Forge, PA30.7MShares$3.35 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY20.9MShares$2.28 Billion0.05% of portfolio
-
State Street Corp Boston, MA13.3MShares$1.45 Billion0.06% of portfolio
-
Capital International Investors Los Angeles, CA8.54MShares$931 Million0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.34MShares$800 Million0.06% of portfolio
-
Terry Smith Fundsmith LLP | London, X06.86MShares$748 Million3.11% of portfolio
-
Massachusetts Financial Services CO Boston, MA6.67MShares$727 Million0.23% of portfolio
-
Geode Capital Management, LLC Boston, MA5.92MShares$645 Million0.05% of portfolio
-
Stifel Financial Corp St. Louis, MO4.32MShares$471 Million0.48% of portfolio
-
Morgan Stanley New York, NY3.48MShares$379 Million0.03% of portfolio
Latest Institutional Activity in CHD
Top Purchases
Top Sells
About CHD
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
Insider Transactions at CHD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 24
2025
|
Lee B Mc Chesney EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,230
+50.0%
|
$2,250,380
$106.9 P/Share
|
Mar 12
2025
|
Rene Hemsey EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
11,060
-46.16%
|
$1,205,540
$109.98 P/Share
|
Mar 12
2025
|
Rene Hemsey EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,060
+31.57%
|
$497,700
$45.76 P/Share
|
Mar 10
2025
|
Surabhi Pokhriyal EVP Chief Digital Growth Offic |
BUY
Grant, award, or other acquisition
|
Indirect |
16
+34.04%
|
$1,776
$111.8 P/Share
|
Mar 10
2025
|
Richard A Dierker EVP, CFO & Head of Business Op |
BUY
Grant, award, or other acquisition
|
Indirect |
30
+3.02%
|
$3,330
$111.8 P/Share
|
Mar 10
2025
|
Joseph James Longo VP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Indirect |
30
+17.65%
|
$3,330
$111.8 P/Share
|
Mar 10
2025
|
Rabago Carlos Ruiz EVP Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2
+50.0%
|
$222
$111.79 P/Share
|
Mar 10
2025
|
Carlen Hooker EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
30
+14.78%
|
$3,330
$111.8 P/Share
|
Mar 10
2025
|
Matthew Farrell President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
98
+5.91%
|
$10,878
$111.8 P/Share
|
Mar 10
2025
|
Brian D Buchert EVP of Strategy, M&A, and BP |
BUY
Grant, award, or other acquisition
|
Indirect |
30
+1.76%
|
$3,330
$111.8 P/Share
|
Mar 10
2025
|
Kevin Gokey EVP Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
93
+2.31%
|
$10,323
$111.8 P/Share
|
Mar 10
2025
|
Patrick D De Maynadier EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
54,510
-83.85%
|
$6,268,650
$115.98 P/Share
|
Mar 10
2025
|
Patrick D De Maynadier EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
54,510
+45.61%
|
$3,979,230
$73.87 P/Share
|
Mar 07
2025
|
Rick Spann EVP Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-25.52%
|
$27,776
$112.33 P/Share
|
Mar 03
2025
|
Joseph James Longo VP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
380
+50.0%
|
-
|
Mar 03
2025
|
Kevin Gokey EVP Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+50.0%
|
-
|
Mar 03
2025
|
Surabhi Pokhriyal EVP Chief Digital Growth Offic |
BUY
Grant, award, or other acquisition
|
Direct |
420
+50.0%
|
-
|
Mar 03
2025
|
Rabago Carlos Ruiz EVP Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
550
+50.0%
|
-
|
Mar 03
2025
|
Brian D Buchert EVP of Strategy, M&A, and BP |
BUY
Grant, award, or other acquisition
|
Direct |
400
+50.0%
|
-
|
Mar 03
2025
|
Carlen Hooker EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
540
+50.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 60.6K shares |
---|---|
Exercise of conversion of derivative security | 1.01M shares |
Open market or private purchase | 1.9K shares |
Open market or private sale | 1.04M shares |
---|---|
Payment of exercise price or tax liability | 4.71K shares |
Bona fide gift | 3.11K shares |